{"product_id":"the-brigham-and-dana-farber-board-review-and-comprehensive-update-in-hematology-and-oncology-2022","title":"The Brigham and Dana-Farber Board Review and Comprehensive Update in Hematology and Oncology 2022","description":"\u003ch3\u003eThe Brigham and Dana-Farber Board Review and Comprehensive Update in Hematology and Oncology 2022\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eTopics\/Speakers\u003c\/strong\u003e\u003c\/p\u003e\n\u003cdiv id=\"tab-description\" class=\"woocommerce-Tabs-panel woocommerce-Tabs-panel--description panel entry-content active\" role=\"tabpanel\" aria-labelledby=\"tab-title-description\"\u003e\n\u003cdiv class=\"tab-panels\"\u003e\n\u003cdiv id=\"tab-description\" class=\"panel entry-content active\"\u003e\n\u003cul\u003e\n\u003cli\u003eMolecular Genetics of Cancer – \u003cem\u003eNikhil Wagle, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eAdvances in Cancer Drug Development Part I – Chemotherapy and Targeted Agents – \u003cem\u003eGeoffrey I. Shapiro, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eAdvances in Cancer Drug Development Part II – Modulation of the Tumor Microenvironment – \u003cem\u003eGeoffrey I. Shapiro, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eInfections in Cancer Patients – \u003cem\u003eLindsey Baden, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eSymptom Management in Patients with Cancer – \u003cem\u003eAndrew J. Lawton, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eCommunication: The Key to Excellence in End-of-Life Care – \u003cem\u003eRachelle E. Bernacki, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eBiology of Hematopoietic Stem Cell Transplantation – \u003cem\u003eRobert J. Soiffer, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eBiology of Acute Leukemia and Myelodysplastic Syndromes – \u003cem\u003eBenjamin L. Ebert, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eAcute Leukemias – \u003cem\u003eDaniel J. DeAngelo, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eMyelodysplastic Syndrome – \u003cem\u003eEric S. Winer, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eChronic Myelogenous Leukemia – \u003cem\u003eMarlise R. Luskin, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eMyeloproliferative Syndromes – \u003cem\u003eAnn M. Mullally, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eMultiple Myeloma – \u003cem\u003eKenneth C. Anderson, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eWaldenstrom Macroglobulemia and Amyloidosis – \u003cem\u003eJorge Castillo, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eLow Grade Lymphomas – \u003cem\u003eCaron A. Jacobson, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eAggressive Non-Hodgkin Lymphoma – \u003cem\u003eEric Jacobsen, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eHodgkin’s Lymphoma – \u003cem\u003eReid W. Merryman, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eDiagnosis and Treatment of CLL and Related B Cell Malignancies – \u003cem\u003eMatthew S. Davids, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eHead and Neck Cancer – \u003cem\u003eRobert I. Haddad, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eNatural History, Screening, and Small Cell Lung Cancer – \u003cem\u003eBruce E. Johnson, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eNon Small Cell Lung Cancer – Part 1 – \u003cem\u003eMark Awad, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eNon Small Cell Lung Cancer – Part 2 – \u003cem\u003eMark Awad, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eMesothelioma and Thymoma – \u003cem\u003eDavid M. Jackman, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eCarcinoid and Neuroendocrine Tumors – \u003cem\u003eJennifer Ang Chan, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eNovel Approaches for the Management of Esophageal and Gastric Cancers – \u003cem\u003ePeter C. Enzinger, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003ePancreatic Cancer – \u003cem\u003eBrian M. Wolpin, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eHepatobiliary Cancer – \u003cem\u003eJames M. Cleary, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eAnal Cancer \u0026amp; Colorectal Cancers Part 1 – \u003cem\u003eRobert J. Mayer, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eColorectal Cancers Part 2 – \u003cem\u003eRobert J. Mayer, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eGastrointestinal Cancer: Genetic Syndromes – \u003cem\u003eMatthew Yurgelun, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eTesticular Cancer – \u003cem\u003eMark M. Pomerantz, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eRenal and Bladder Cancer – \u003cem\u003eGuru P. Sonpavde, MBBS\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eProstate Cancer Part I: Overview and Management of Localized Disease – \u003cem\u003eAtish Choudhury, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eProstate Cancer Part II: Management of Disseminated Prostate Cancer – \u003cem\u003eAtish Choudhury, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eMelanoma – \u003cem\u003eF. Stephen Hodi, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eSarcomas and Gastrointestinal Stromal Tumors (GIST) – \u003cem\u003eSuzanne George, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eMolecular Advances and Emerging Treatment Strategies in Ovarian Cancer – \u003cem\u003eUrsula A. Matulonis, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eCervical and Endometrial Cancer – \u003cem\u003ePanagiotis A. Konstantinopoulos, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eNeuro-oncology – \u003cem\u003eDavid A. Reardon, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eBreast Cancer – Risk Factors, Genetics, Screening, and Prevention – \u003cem\u003eJudy E. Garber, MD, MPH\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eMultimodality Therapy for Early Stage Breast Cancer: Part 1 – Surgery and Radiation – \u003cem\u003eHarold J. Burstein, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eMultimodality Therapy for Early Stage Breast Cancer: Part 2 – Systemic Therapy – \u003cem\u003eHarold J. Burstein, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eManagement of Metastatic Breast Cancer – \u003cem\u003eAdrienne G. Waks, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eBreast Cancer Survivorship – \u003cem\u003eAnn H. Partridge, MD, MPH\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eHematopoiesis and Cytokines – \u003cem\u003eDavid T. Scadden, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eAcquired Bone Marrow Failure – \u003cem\u003eJulie-Aurore Losman, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eCongenital Bone Marrow Failure – \u003cem\u003eAkiko Shimamura, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eHemophagocytic Syndromes and Related Immunodeficiencies – \u003cem\u003eBarbara A. Degar, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eAnemia – An Overview – \u003cem\u003eRobert Stern, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eIron Deficiency and Iron Overload – \u003cem\u003eMark D. Fleming, MD, Dphil\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eImmune Hemolytic Anemia – \u003cem\u003eRichard M. Kaufman, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eNon-immune Hemolytic Anemia – \u003cem\u003eDavid E. Golan, PhD, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eSickle Cell Disease – \u003cem\u003eMaureen M. Achebe, MD, MPH\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eThalassemia and Other Hemoglobinopathies – \u003cem\u003eMatthew M. Heeney, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eDisorders of Neutrophils – \u003cem\u003eNancy Berliner, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eAcquired Thrombocytopenias – \u003cem\u003eElisabeth M. Battinelli, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eHemophilia – \u003cem\u003eAric D. Parnes, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eVon Willebrand Disease and Congenital Platelet Disorders – \u003cem\u003eNathan T. Connell, MD, MPH\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eCongenital and Acquired Thrombophilia – \u003cem\u003eKenneth A. Bauer, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eUse of Direct Oral Anticoagulants in Clinical Practice – \u003cem\u003eJean M. Connors, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eTransfusion Medicine for the Clinician – \u003cem\u003eWalter H. Dzik, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"container\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n","brand":"My Store","offers":[{"title":"Default Title","offer_id":42954638196834,"sku":"MED-AMB07298","price":50.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/The-Brigham-and-Dana-Farber-Board-Review-and-Comprehensive-Update-in.jpg?v=1779381370","url":"https:\/\/meducourse.com\/products\/the-brigham-and-dana-farber-board-review-and-comprehensive-update-in-hematology-and-oncology-2022","provider":"Meducourse","version":"1.0","type":"link"}